Leadership and Faculty
Laura Haneline, MD
Director, Section of Neonatal-Perinatal Medicine
Title: Edwin L. Gresham Professor of Pediatrics
Professor of Microbiology and Immunology
Awards & Honors:
Dr. Haneline is a stem cell biologist whose research focuses on how dysfunction of stem and progenitor cells impacts the pathogenesis of hematopoietic and vascular diseases. Her laboratory is actively investigating whether pathologic oxidative stress encountered by either a child with type 1 diabetes or a fetus exposed to a diabetic intrauterine environment leads to altered endothelial progenitor cell function. She is involved in an NIH-funded Obstetric-Fetal Pharmacologic Research Unit Network that proposes basic and translational pharmacologic studies of drug disposition and effect on endothelial progenitor cell subsets during normal and abnormal pregnancies. Dr. Haneline is working with collaborators to explore the potential role of endothelial progenitor cell dysfunction in type 1 diabetes and childhood obesity.
William A. Engle, MD
Director of Clinical Affairs, Section of Neonatal-Perinatal Medicine
Title: Erik T. Ragan Professor of Pediatrics
Awards & Honors:
Clinical service to sick neonates and their parents is his major focus for Dr. Engle. He is the Co-Director of the Neonatal ECMO Program, Medical Director of Riley NICU, Director of Clinical Affairs, and serves the Department of Pediatrics, the School of Medicine and the Medical Staff in several administrative capacities. Dr. Engle participates in medical training through bedside and didactic education and in a number of diverse quality improvement and research projects that focus on extracorporeal membrane oxygenation, bronchopulmonary dysplasia, infection control, oxygen saturation limits in extremely preterm infants, and resuscitation of high risk newborns. He currently serves as co-editor of NeoReviews and helps direct an online education program sponsored by the American Academy of Pediatrics.